AU2003229767A8 - Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) - Google Patents

Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)

Info

Publication number
AU2003229767A8
AU2003229767A8 AU2003229767A AU2003229767A AU2003229767A8 AU 2003229767 A8 AU2003229767 A8 AU 2003229767A8 AU 2003229767 A AU2003229767 A AU 2003229767A AU 2003229767 A AU2003229767 A AU 2003229767A AU 2003229767 A8 AU2003229767 A8 AU 2003229767A8
Authority
AU
Australia
Prior art keywords
ccr9
therapeutics
diagnostics
diseases associated
chemokine receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229767A
Other versions
AU2003229767A1 (en
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003229767A1 publication Critical patent/AU2003229767A1/en
Publication of AU2003229767A8 publication Critical patent/AU2003229767A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003229767A 2002-05-14 2003-05-02 Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) Abandoned AU2003229767A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02010163 2002-05-14
EP02010163.0 2002-05-14
PCT/EP2003/004597 WO2003095967A2 (en) 2002-05-14 2003-05-02 Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)

Publications (2)

Publication Number Publication Date
AU2003229767A1 AU2003229767A1 (en) 2003-11-11
AU2003229767A8 true AU2003229767A8 (en) 2003-11-11

Family

ID=29414671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229767A Abandoned AU2003229767A1 (en) 2002-05-14 2003-05-02 Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)

Country Status (2)

Country Link
AU (1) AU2003229767A1 (en)
WO (1) WO2003095967A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0227989D0 (en) * 2002-12-02 2003-01-08 Imp College Innovations Ltd Chimaeric molecules
EP3416640A1 (en) 2016-02-16 2018-12-26 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Modulators of tumor immune resistance for the treatment of cancer
US20190054110A1 (en) 2016-02-16 2019-02-21 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Modulators of ccr9 for treating tumor resistance to immune responses
CN113502271B (en) * 2021-07-20 2023-08-11 广州赛隽生物科技有限公司 Mesenchymal stem cells for treating inflammatory bowel disease and application thereof
CN115006423B (en) * 2022-06-28 2023-07-18 四川大学 Application of tetrahedral framework nucleic acid in preparation of medicine for preventing and/or treating brain trauma sequelae

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329159B1 (en) * 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
JP2002345487A (en) * 2000-09-05 2002-12-03 Teijin Ltd New protein, dna and use thereof
EP2402310A1 (en) * 2002-05-24 2012-01-04 Millennium Pharmaceuticals, Inc. CCR9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
WO2003095967A2 (en) 2003-11-20
WO2003095967A3 (en) 2004-04-01
AU2003229767A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003214249A1 (en) Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
AU2003214072A8 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003229767A8 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003273994A8 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003250221A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6)
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003233333A8 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (ccr10)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003232750A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
AU2003216866A8 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003276106A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
AU2003240639A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
AU2003227751A1 (en) Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
AU2003301892A8 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)
AU2003274005A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6)
AU2003221502A8 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
AU2003238174A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 3 (sstr3)
AU2003227064A8 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 484 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BAYER HEALTHCARE AG, APPLICATION NO. 2003229767, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003